• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Cato van den Berg
Cato van den Berg
Cato van den Berg

Cato van den Berg

Associate

  • Eindhoven Netherlands
Contact Me Today
+31 88 0243 081
vCard
Email me Call me

Cato is an associate in our Restructuring & Insolvency team. Cato advises clients on all matters of insolvency law, restructuring, financing and securities.

Expertise

Services and Groups

Restructuring & insolvency

Sectors

Business & professional services
Technology, media & communications
Life sciences & healthcare

CV

Since 2026 Associate, Taylor Wessing
2025 LLM, Ondernemingsrecht (with distinction), Tilburg University
2023 LLB, Ondernemingsrecht, Tilburg University

Career

Since 2026 Associate, Taylor Wessing

Education

2025 LLM, Ondernemingsrecht (with distinction), Tilburg University
2023 LLB, Ondernemingsrecht, Tilburg University

Additional languages

English Dutch

Related news & insights

Robots hand
Technology, media & communications

The EU Digital Omnibus on AI – What the political deal means

8 May 2026
In-depth analysis

by multiple authors

Click here to find out more
White microscope on yellow background
Banking & finance

Cabinet decision on the Statutory Health Insurance Contribution Stabilization Act – Financial burdens on German pharmaceutical companies

4 May 2026
Briefing

by Dr. Daniel Tietjen and Ennio Schwind, LL.M. Eur.

Click here to find out more
Pipette injecting liquid into microtiter plate on white background
Life sciences & healthcare

Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products

29 April 2026
Briefing

by Daniel Dietrich and Dr. Daniel Tietjen

Click here to find out more
DNA helix
Life sciences & healthcare

CJEU Advocate General on Distributors’ Obligations for Medical Devices

29 April 2026
Briefing

by Dr. Daniel Tietjen and Daniel Dietrich

Click here to find out more
Close-Up Of Lady Justice
Life sciences & healthcare

Federal Court of Justice Ruling on Public Advertising for Medical Cannabis on Online Platforms

24 April 2026
Quick read

by multiple authors

Click here to find out more
Android with arm out
Technology, media & communications

Law Against Digital Violence – New Obligations for Online Service Providers

24 April 2026
Briefing

by Dr. Paul Voigt, Lic. en Derecho, CIPP/E and Dr. Jakob Horn, LL.M. (Harvard)

Click here to find out more
FinTech Stories
Fintech

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

22 April 2026

by Miroslav Đurić, LL.M.

Click here to find out more
Color pencils

Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act

21 April 2026
Briefing

by multiple authors

Click here to find out more
ivdr mdr
Medical devices

Proposed Amendments to the EU Medical Device Regulation

15 April 2026
Briefing

by Bartosz Świdrak

Click here to find out more
biotech helix
Biotech

Impact of the new Biotech Act on Clinical Trials in the EU

15 April 2026
Quick read

by Irina Rebin

Click here to find out more
View all insights

Related people

Netherlands
Ilona van de Klundert

Ilona van de Klundert

Partner

Eindhoven
+31 88 02 43 079
Email me
View profile
Bob Rikkert

Bob Rikkert

Counsel

Eindhoven
+31 88 02 43 074
Email me
View profile
Feiven Sereke

Feiven Sereke

Senior Associate

Eindhoven
+31 88 02 43 073
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing